Report Detail
Global Enzalutamide API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4638800 |
- 24 October, 2025 |
- Global |
- 95 Pages |
- GIR |
- Chemical & Material
According to our (Global Info Research) latest study, the global Enzalutamide API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Through a mechanism that is reported to be different from other approved AR antagonists, enzalutamide inhibits the activity of prostate cancer cell ARs, which may result in a reduction in prostate cancer cell proliferation and, correspondingly, a reduction in the serum prostate specific antigen (PSA) level. AR over-expression in prostate cancer represents a key mechanism associated with prostate cancer hormone resistance.
This report is a detailed and comprehensive analysis for global Enzalutamide API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Enzalutamide API market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Enzalutamide API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Enzalutamide API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2020-2031
Global Enzalutamide API market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enzalutamide API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enzalutamide API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Shilpa Medicare Limited, ScinoPharm Taiwan, Ltd, Olon Spa, Farmhispania, S.A., Mac-Chem Products (India) Pvt.Ltd, Shandong Haohong Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Enzalutamide API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Enzalutamide Capsules
Others
Major players covered
Dr. Reddy’s Laboratories Ltd.
Shilpa Medicare Limited
ScinoPharm Taiwan, Ltd
Olon Spa
Farmhispania, S.A.
Mac-Chem Products (India) Pvt.Ltd
Shandong Haohong Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Enzalutamide API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enzalutamide API, with price, sales quantity, revenue, and global market share of Enzalutamide API from 2020 to 2025.
Chapter 3, the Enzalutamide API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enzalutamide API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Enzalutamide API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enzalutamide API.
Chapter 14 and 15, to describe Enzalutamide API sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Enzalutamide API Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Purity≥98%
- 1.3.3 Purity<98%
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Enzalutamide API Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Enzalutamide Capsules
- 1.4.3 Others
- 1.5 Global Enzalutamide API Market Size & Forecast
- 1.5.1 Global Enzalutamide API Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Enzalutamide API Sales Quantity (2020-2031)
- 1.5.3 Global Enzalutamide API Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 Dr. Reddy’s Laboratories Ltd.
- 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
- 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
- 2.1.3 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Product and Services
- 2.1.4 Dr. Reddy’s Laboratories Ltd. Enzalutamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
- 2.2 Shilpa Medicare Limited
- 2.2.1 Shilpa Medicare Limited Details
- 2.2.2 Shilpa Medicare Limited Major Business
- 2.2.3 Shilpa Medicare Limited Enzalutamide API Product and Services
- 2.2.4 Shilpa Medicare Limited Enzalutamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Shilpa Medicare Limited Recent Developments/Updates
- 2.3 ScinoPharm Taiwan, Ltd
- 2.3.1 ScinoPharm Taiwan, Ltd Details
- 2.3.2 ScinoPharm Taiwan, Ltd Major Business
- 2.3.3 ScinoPharm Taiwan, Ltd Enzalutamide API Product and Services
- 2.3.4 ScinoPharm Taiwan, Ltd Enzalutamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 ScinoPharm Taiwan, Ltd Recent Developments/Updates
- 2.4 Olon Spa
- 2.4.1 Olon Spa Details
- 2.4.2 Olon Spa Major Business
- 2.4.3 Olon Spa Enzalutamide API Product and Services
- 2.4.4 Olon Spa Enzalutamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Olon Spa Recent Developments/Updates
- 2.5 Farmhispania, S.A.
- 2.5.1 Farmhispania, S.A. Details
- 2.5.2 Farmhispania, S.A. Major Business
- 2.5.3 Farmhispania, S.A. Enzalutamide API Product and Services
- 2.5.4 Farmhispania, S.A. Enzalutamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Farmhispania, S.A. Recent Developments/Updates
- 2.6 Mac-Chem Products (India) Pvt.Ltd
- 2.6.1 Mac-Chem Products (India) Pvt.Ltd Details
- 2.6.2 Mac-Chem Products (India) Pvt.Ltd Major Business
- 2.6.3 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Product and Services
- 2.6.4 Mac-Chem Products (India) Pvt.Ltd Enzalutamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Mac-Chem Products (India) Pvt.Ltd Recent Developments/Updates
- 2.7 Shandong Haohong Biotechnology
- 2.7.1 Shandong Haohong Biotechnology Details
- 2.7.2 Shandong Haohong Biotechnology Major Business
- 2.7.3 Shandong Haohong Biotechnology Enzalutamide API Product and Services
- 2.7.4 Shandong Haohong Biotechnology Enzalutamide API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Shandong Haohong Biotechnology Recent Developments/Updates
3 Competitive Environment: Enzalutamide API by Manufacturer
- 3.1 Global Enzalutamide API Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Enzalutamide API Revenue by Manufacturer (2020-2025)
- 3.3 Global Enzalutamide API Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Enzalutamide API by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Enzalutamide API Manufacturer Market Share in 2024
- 3.4.3 Top 6 Enzalutamide API Manufacturer Market Share in 2024
- 3.5 Enzalutamide API Market: Overall Company Footprint Analysis
- 3.5.1 Enzalutamide API Market: Region Footprint
- 3.5.2 Enzalutamide API Market: Company Product Type Footprint
- 3.5.3 Enzalutamide API Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Enzalutamide API Market Size by Region
- 4.1.1 Global Enzalutamide API Sales Quantity by Region (2020-2031)
- 4.1.2 Global Enzalutamide API Consumption Value by Region (2020-2031)
- 4.1.3 Global Enzalutamide API Average Price by Region (2020-2031)
- 4.2 North America Enzalutamide API Consumption Value (2020-2031)
- 4.3 Europe Enzalutamide API Consumption Value (2020-2031)
- 4.4 Asia-Pacific Enzalutamide API Consumption Value (2020-2031)
- 4.5 South America Enzalutamide API Consumption Value (2020-2031)
- 4.6 Middle East & Africa Enzalutamide API Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Enzalutamide API Sales Quantity by Type (2020-2031)
- 5.2 Global Enzalutamide API Consumption Value by Type (2020-2031)
- 5.3 Global Enzalutamide API Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Enzalutamide API Sales Quantity by Application (2020-2031)
- 6.2 Global Enzalutamide API Consumption Value by Application (2020-2031)
- 6.3 Global Enzalutamide API Average Price by Application (2020-2031)
7 North America
- 7.1 North America Enzalutamide API Sales Quantity by Type (2020-2031)
- 7.2 North America Enzalutamide API Sales Quantity by Application (2020-2031)
- 7.3 North America Enzalutamide API Market Size by Country
- 7.3.1 North America Enzalutamide API Sales Quantity by Country (2020-2031)
- 7.3.2 North America Enzalutamide API Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Enzalutamide API Sales Quantity by Type (2020-2031)
- 8.2 Europe Enzalutamide API Sales Quantity by Application (2020-2031)
- 8.3 Europe Enzalutamide API Market Size by Country
- 8.3.1 Europe Enzalutamide API Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Enzalutamide API Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Enzalutamide API Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Enzalutamide API Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Enzalutamide API Market Size by Region
- 9.3.1 Asia-Pacific Enzalutamide API Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Enzalutamide API Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Enzalutamide API Sales Quantity by Type (2020-2031)
- 10.2 South America Enzalutamide API Sales Quantity by Application (2020-2031)
- 10.3 South America Enzalutamide API Market Size by Country
- 10.3.1 South America Enzalutamide API Sales Quantity by Country (2020-2031)
- 10.3.2 South America Enzalutamide API Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Enzalutamide API Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Enzalutamide API Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Enzalutamide API Market Size by Country
- 11.3.1 Middle East & Africa Enzalutamide API Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Enzalutamide API Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Enzalutamide API Market Drivers
- 12.2 Enzalutamide API Market Restraints
- 12.3 Enzalutamide API Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Enzalutamide API and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Enzalutamide API
- 13.3 Enzalutamide API Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Enzalutamide API Typical Distributors
- 14.3 Enzalutamide API Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Enzalutamide API. Industry analysis & Market Report on Enzalutamide API is a syndicated market report, published as Global Enzalutamide API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Enzalutamide API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
